Anti-pd1 antibodies and their use as therapeutics and diagnostics
US-2025059277-A1 · Feb 20, 2025 · US
Xu Lanlan is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Xu Lanlan |
| Total patents | 15 |
| First publication | Mar 19, 2015 |
| Latest publication | Feb 20, 2025 |
Publications ranked by popularity score, then publication date.
US-2025059277-A1 · Feb 20, 2025 · US
US-2023303689-A1 · Sep 28, 2023 · US
US-11673951-B2 · Jun 13, 2023 · US
US-2022119524-A1 · Apr 21, 2022 · US
US-11186637-B2 · Nov 30, 2021 · US
US-2021230274-A1 · Jul 29, 2021 · US
US-2020216535-A1 · Jul 9, 2020 · US
US-10519235-B2 · Dec 31, 2019 · US
US-2018251551-A1 · Sep 6, 2018 · US
US-9988450-B2 · Jun 5, 2018 · US
Latest publications not already listed above.
US-2018111995-A1 · Apr 26, 2018 · US
US-9834606-B2 · Dec 5, 2017 · US
US-9217034-B2 · Dec 22, 2015 · US
US-2015315274-A1 · Nov 5, 2015 · US
US-2015079109-A1 · Mar 19, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Beigene Ltd | 9 |
| Beigene Switzerland Gmbh | 6 |
| Beigene Switzerland Gmbh | 3 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/76 | 15 |
| C07K2317/73 | 15 |
| C07K2317/71 | 15 |
| C07K2317/70 | 15 |
| C07K2317/569 | 15 |